Comparative effects of cetaben (PHB) and dichlormethylene diphosphonate (Cl2MDP) on the development of atherosclerosis in the cynomolgus monkey

      This paper is only available as a PDF. To read, Please Download here.


      The comparative effects of cetaben [sodium p-hexadecylaminobenzoate, (PHB)] and dichloromethylene diphosphate (Cl2MDP) on the development of atherosclerosis was investigated in the cynomolgus monkey. The atherosclerosis was induced by feeding a 2.5% cholesterol and 10% butter diet for 6 months and was assessed by morphological and biochemical examination of the arteries at necropsy. The experimental disease was also evaluated clinically by the electrocardiographic responses to isoproterenol and by measurements of regional myocardial blood flow using microspheres. Both the clinical and necropsy findings indicated that PHB was an effective antiatherosclerotic agent which reduced the extent and severity of the disease and protected against obstructive atherosclerotic disease of the coronary and peripheral arteries. On the other hand, (CL2MDP) was found to have no antiatherosclerotic effect except for preventing calcium deposition in the induced lesions. The atherosclerotic narrowing of the major coronary arteries in the PHB-treated group averaged about 27% as compared to 55% in the untreated animals. PHB also reduced the luminal narrowing of the carotid, subclavian, iliac and tibial arteries by 50% or more. The drug had actions on both the circulating blood and arteries that could account for its antiatherosclerotic effects. These actions included a lowering of plasma cholesterol and an effect on the plasma lipoproteins resulting in a decrease in LDL and an increase in HDL. Other important actions of PHB included the inhibition of calcium, cholesterol and cholesteryl ester deposition in the induced lesions as well as reduction in the fibrous protein content of the lesions.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wartman A.
        • Lampe T.L.
        • McCann D.S.
        • Boyle A.J.
        Plaque reversal with MgEDTA in experimental atherosclerosis — Elastin and collagen metabolism.
        J. Atheroscler. Res. 1967; 7: 331
        • Whittington-Coleman P.J.
        • Carrier Jr., O.
        Effects of agents altering vascular calcium in experimental atherosclerosis.
        Atherosclerosis. 1970; 12: 15
        • Whittington-Coleman P.J.
        • Carrier Jr., O.
        • Douglas B.H.
        The effects of propranolol on cholesterol-induced atheromatous lesions.
        Atherosclerosis. 1973; 18: 337
        • Katocs Jr., A.S.
        • Schaffer S.A.
        Antiatherogenic activity of CL 203,821, sodium p-hexadecyl-aminobenzoate (1), in cholesterol-fed rabbits subjected to aortic endothelial-cell-denudation (ECD).
        in: Fed. Proc.36. 1977: 1160
        • Hollander W.
        • Prusty S.
        • Nagraj S.
        • Kirkpatrick B.
        • Paddock J.
        • Colombo M.
        Comparative antiatherosclerotic effects of antiplatelet, anticalcifying and antilipemic drugs with special reference to sodium P-hexadecylaminobenzoate (PHB).
        in: Proc. 6th International Symposium on Drugs Affecting Lipid Metabolism, Philadelphia1977
        • Hollander W.
        • McCombs H.L.
        • Franzblau C.
        • Kirkpatrick B.
        • Schmid K.
        Influence of the anticalcifying agent, ethane-1-hydroxy-1,1-diphosphonate (EHDP) on pre-established atheromata in rabbits.
        Circulation. 1974; 50: 3
        • Rosenblum I.Y.
        • Flora L.
        • Eisenstein R.
        The effect of disodium ethane-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis.
        Atherosclerosis. 1975; 22: 411
        • Kramsch D.M.
        • Chan C.T.
        Effects of ethane-hydroxy-diphosphonate (EHDP) and n-acetyl-nmethyl-colchicine (Colcemid) on progression and regression of experimental atherosclerosis.
        in: Fed. Proc.34. 1975: 235
        • Wagner W.D.
        • Clarkson T.B.
        • Foster J.
        Contrasting effects of ethane-1-hydroxy-1,1-diphos-phonate (EHDP) on the regression of two types of dietary-induced atherosclerosis.
        Atherosclerosis. 1977; 27: 419
        • Hollander W.
        Unified concept on the role of acid mucopolysaccharides and connective tissue proteins in the accumulation of lipids, lipoproteins and calcium in the atherosclerotic plaque.
        Exp. Mol. Path. 1976; 25: 106
        • Rodan G.A.
        • Boyrret L.A.
        • Norton L.A.
        DNA synthesis in cartilate cells is stimulated by oscillating electric fields.
        Science. 1977; 199: 690
        • Reiner K.A.
        • Lowe J.A.
        • Jennings R.B.
        Effect of the calcium antagonist Verapamil on necrosis following temporary coronary artery occlusion in drugs.
        Circulation. 1977; 55: 581
        • Schoenheimer R.
        • Sperry W.M.
        Micromethod for the determination of free and combined cholesterol.
        J. Biol. Chem. 1934; 106: 145
        • Van Handel E.
        • Zilversmit D.B.
        Micromethod for the direct determination of serum triglycerides.
        J. Lab. Clin. Med. 1957; 50: 152
        • Havel R.J.
        • Eder H.A.
        • Bragdon J.H.
        The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.
        J. Clin. Invest. 1955; 34: 1345
        • Hollander W.
        • Prusty S.
        • Kirkpatrick B.
        • Paddock J.
        • Nagraj S.
        Role of hypertension in ischemic heart disease and cerebral vascular disease in the cynomolgus monkey with coarctation of the aorta.
        Circ. Res. 1977; 40: 1-70
        • Prusty S.
        • Paddock J.
        • Nagraj S.
        • Hollander W.
        Comparative effects of hypertension and coronary atherosclerosis on regional coronary blood flow in the cynomolgus monkey.
        Circulation. 1977; 55 and 56: 36
        • Buckberg G.D.
        • Fixler D.E.
        • Archie J.P.
        • Hoffman J.I.E.
        Experimental subendocardial ischemia in dogs with normal coronary arteries.
        Circ. Res. 1972; 30: 67
        • Jones R.M.
        • Goodale F.
        Improvements in the methods of embedding tissues in carbowax.
        Amer. J. Clin. Path. 1962; 38: 173
        • Armstrong M.L.
        • Warner E.D.
        • Connor W.E.
        Regression of coronary atheromatosis in rhesus monkeys.
        Circ. Res. 1970; 27: 59
        • Holman R.L.
        • McGill Jr., H.C.
        • Strong J.P.
        • Geer J.C.
        Technics for studying atherosclerotic lesions.
        Lab. Invest. 1958; 7: 42
        • Hollander W.
        • Kramsch D.M.
        • Franzblau C.
        • Paddock J.
        • Colombo M.A.
        Suppression of atheromatous fibrous plaque formation by antiproliferative and anti-inflammatory drugs.
        Circ. Res. 1974; 34 and 35: I-131
        • Wolinsky H.
        • Daly M.M.
        Method for the isolation of intima-media samples from arteries.
        in: Proc. Soc. Exp. Biol. Med.135. 1970: 364
        • Folch J.
        • Lees M.
        • Sloane-Stanley G.H.
        Simple method for the isolation and Purification of total lipids from animal tissues.
        J. Biol. Chem. 1957; 226: 497
        • Lansing A.I.
        • Rosenthal T.B.
        • Alex M.
        • Dempsey E.W.
        Structure and chemical characterization of elastic fibers as revealed by elastase and by electron microscopy.
        Anat. Rec. 1952; 114: 555
        • Bergman I.
        • Loxley R.
        Lung tissue hydrolysates — Studies of the optimum conditions for the spectrophotometric determination of hydroxyproline.
        Analyst. 1969; 94: 575
        • Wallach D.F.H.
        • Steck T.L.
        Fluorescent technique in the microdetermination of metals in biological materials.
        Anal. Chem. 1963; 35: 1035
        • Zwolak R.M.
        • Malik A.B.
        • Morrison E.S.
        • Scott F.
        Regional coronary vascular reserve in experimental atherosclerosis.
        Circulation. 1977; 56: III-37
        • Largis E.E.
        • Katocs Jr., A.S.
        • Will L.
        • McClintock D.K.
        • Schaffer S.A.
        • Alkylamino-benzoic acids as hypolipidemic and antiatherogenic agents
        J. Amer. Oil Chemists Soc. 1976; 53: 140A
        • Hollander W.
        • Madoff I.M.
        • Paddock J.
        • Kirkpatrick B.
        Aggravation of atherosclerosis by hypertension in a subhuman primate model with coarctation of the aorta.
        Circ. Res. 1976; 38: II-63
        • Rudel L.L.
        • Lofland H.B.
        Circulating lipoproteins in non-human primates.
        in: Atherosclerosis in Primates. Primates in Medicine. Vol. 9. S. Karger, Basel1976: 224
        • Rhoads G.G.
        • Gulbrandsen C.L.
        • Kagan A.
        Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.
        New Engl. J. Med. 1976; 294: 293
        • Rudell L.L.
        • Greene D.G.
        • Shah R.
        Separation and characterization of plasma lipoproteins of rhesus monkeys (Macaca mulatta).
        J. Lipid Res. 1977; 18: 734